{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T17:59:37Z","timestamp":1775930377810,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100009609","name":"Hospital Infantil de M\u00e9xico Federico G\u00f3mez","doi-asserted-by":"publisher","award":["Fondos Federales HIM\/2019\/029 SSA. 1575"],"award-info":[{"award-number":["Fondos Federales HIM\/2019\/029 SSA. 1575"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100009609","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s12013-022-01116-x","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T09:03:21Z","timestamp":1667898201000},"page":"105-115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Atomoxetine Decreases Mitochondrial Biogenesis, Fission and Fusion In Human Neuron-like Cells But Does Not Alter Antioxidant Defences"],"prefix":"10.1007","volume":"81","author":[{"given":"Sonia","family":"Carre\u00f3n-Trujillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"V\u00e1zquez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4907-437X","authenticated-orcid":false,"given":"Juan Carlos","family":"Corona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"issue":"10222","key":"1116_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0140-6736(19)33004-1","volume":"395","author":"J Posner","year":"2020","unstructured":"Posner, J., Polanczyk, G. V., & Sonuga-Barke, E. (2020). Attention-deficit hyperactivity disorder. Lancet, 395(10222), 450\u2013462. https:\/\/doi.org\/10.1016\/S0140-6736(19)33004-1.","journal-title":"Lancet"},{"issue":"11","key":"1116_CR2","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1056\/NEJMra1917069","volume":"383","author":"S Cortese","year":"2020","unstructured":"Cortese, S. (2020). Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder. New England Journal of Medicine, 383(11), 1050\u20131056. https:\/\/doi.org\/10.1056\/NEJMra1917069.","journal-title":"New England Journal of Medicine"},{"key":"1116_CR3","doi-asserted-by":"publisher","first-page":"4067597","DOI":"10.1155\/2018\/4067597","volume":"2018","author":"JC Corona","year":"2018","unstructured":"Corona, J. C. (2018). Natural Compounds for the Management of Parkinson\u2019s Disease and Attention-Deficit\/Hyperactivity Disorder. BioMed Research International, 2018, 4067597 https:\/\/doi.org\/10.1155\/2018\/4067597.","journal-title":"BioMed Research International"},{"key":"1116_CR4","first-page":"1","volume-title":"Attention-Deficit Hyperactivity Disorder: Diagnosis, Prevalence and Treatment","author":"JC Corona","year":"2021","unstructured":"Corona, J. C. (2021). Pharmacological approaches for the treatment of Attention-deficit\/hyperactivity disorder. In B. M. Kyser (ed), Attention-Deficit Hyperactivity Disorder: Diagnosis, Prevalence and Treatment (pp. 1\u201339). New York: Nova Science Publishers, Inc. pp."},{"issue":"4","key":"1116_CR5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1586\/ern.10.17","volume":"10","author":"JP Genro","year":"2010","unstructured":"Genro, J. P., Kieling, C., Rohde, L. A., & Hutz, M. H. (2010). Attention-deficit\/hyperactivity disorder and the dopaminergic hypotheses. Expert Review of Neurotherapeutics, 10(4), 587\u2013601. https:\/\/doi.org\/10.1586\/ern.10.17.","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"1","key":"1116_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11065-007-9019-9","volume":"17","author":"JM Swanson","year":"2007","unstructured":"Swanson, J. M., Kinsbourne, M., Nigg, J., Lanphear, B., Stefanatos, G. A., Volkow, N., Taylor, E., Casey, B. J., Castellanos, F. X., & Wadhwa, P. D. (2007). Etiologic subtypes of attention-deficit\/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychology Review, 17(1), 39\u201359. https:\/\/doi.org\/10.1007\/s11065-007-9019-9.","journal-title":"Neuropsychology Review"},{"issue":"3 Suppl 2","key":"1116_CR7","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1097\/JCP.0b013e318174f92a","volume":"28","author":"J Prince","year":"2008","unstructured":"Prince, J. (2008). Catecholamine dysfunction in attention-deficit\/hyperactivity disorder: an update. Journal of Clinical Psychopharmacology, 28(3 Suppl 2), S39\u2013S45. https:\/\/doi.org\/10.1097\/JCP.0b013e318174f92a.","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"12","key":"1116_CR8","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1016\/j.biopsych.2011.02.036","volume":"69","author":"N Del Campo","year":"2011","unstructured":"Del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W. (2011). The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit\/hyperactivity disorder. Biological Psychiatry, 69(12), e145\u2013e157. https:\/\/doi.org\/10.1016\/j.biopsych.2011.02.036.","journal-title":"Biological Psychiatry"},{"issue":"5","key":"1116_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","volume":"27","author":"FP Bymaster","year":"2002","unstructured":"Bymaster, F. P., Katner, J. S., Nelson, D. L., Hemrick-Luecke, S. K., Threlkeld, P. G., Heiligenstein, J. H., Morin, S. M., Gehlert, D. R., & Perry, K. W. (2002). Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder. Neuropsychopharmacology, 27(5), 699\u2013711. https:\/\/doi.org\/10.1016\/S0893-133X(02)00346-9.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"1116_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1471-4159.2010.06750.x","volume":"114","author":"K Koda","year":"2010","unstructured":"Koda, K., Ago, Y., Cong, Y., Kita, Y., Takuma, K., & Matsuda, T. (2010). Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. Journal of Neurochemistry, 114(1), 259\u2013270. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06750.x.","journal-title":"Journal of Neurochemistry"},{"issue":"6","key":"1116_CR11","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.neuropharm.2005.11.022","volume":"50","author":"CJ Swanson","year":"2006","unstructured":"Swanson, C. J., Perry, K. W., Koch-Krueger, S., Katner, J., Svensson, K. A., & Bymaster, F. P. (2006). Effect of the attention deficit\/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Neuropharmacology, 50(6), 755\u2013760. https:\/\/doi.org\/10.1016\/j.neuropharm.2005.11.022.","journal-title":"Neuropharmacology"},{"issue":"3","key":"1116_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1017\/S1461145705005249","volume":"8","author":"T Moran-Gates","year":"2005","unstructured":"Moran-Gates, T., Zhang, K., Baldessarini, R. J., & Tarazi, F. I. (2005). Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder. International Journal of Neuropsychopharmacology, 8(3), 439\u2013444. https:\/\/doi.org\/10.1017\/S1461145705005249.","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"1","key":"1116_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49609-9","volume":"9","author":"JC Corona","year":"2019","unstructured":"Corona, J. C., Carreon-Trujillo, S., Gonzalez-Perez, R., Gomez-Bautista, D., Vazquez-Gonzalez, D., & Salazar-Garcia, M. (2019). Atomoxetine produces oxidative stress and alters mitochondrial function in human neuron-like cells. Scientific Reports, 9(1), 13011 https:\/\/doi.org\/10.1038\/s41598-019-49609-9.","journal-title":"Scientific Reports"},{"key":"1116_CR14","doi-asserted-by":"crossref","unstructured":"Ighodaro OMA, O.A. (2018). First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria Journal of Medicine, 54(4), 287\u2013293.","DOI":"10.1016\/j.ajme.2017.09.001"},{"issue":"1\u20132","key":"1116_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10863-014-9576-6","volume":"47","author":"JC Corona","year":"2015","unstructured":"Corona, J. C., & Duchen, M. R. (2015). Impaired mitochondrial homeostasis and neurodegeneration: towards new therapeutic targets? Journal of Bioenergetics and Biomembranes, 47(1\u20132), 89\u201399. https:\/\/doi.org\/10.1007\/s10863-014-9576-6.","journal-title":"Journal of Bioenergetics and Biomembranes"},{"key":"1116_CR16","doi-asserted-by":"publisher","first-page":"101674","DOI":"10.1016\/j.redox.2020.101674","volume":"37","author":"D Nolfi-Donegan","year":"2020","unstructured":"Nolfi-Donegan, D., Braganza, A., & Shiva, S. (2020). Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biology, 37, 101674 https:\/\/doi.org\/10.1016\/j.redox.2020.101674.","journal-title":"Redox Biology"},{"issue":"4","key":"1116_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41580-020-0210-7","volume":"21","author":"M Giacomello","year":"2020","unstructured":"Giacomello, M., Pyakurel, A., Glytsou, C., & Scorrano, L. (2020). The cell biology of mitochondrial membrane dynamics. Nature Reviews Molecular Cell Biology, 21(4), 204\u2013224. https:\/\/doi.org\/10.1038\/s41580-020-0210-7.","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"3","key":"1116_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1042\/EBC20170104","volume":"62","author":"L Tilokani","year":"2018","unstructured":"Tilokani, L., Nagashima, S., Paupe, V., & Prudent, J. (2018). Mitochondrial dynamics: overview of molecular mechanisms. Essays in Biochemistry, 62(3), 341\u2013360. https:\/\/doi.org\/10.1042\/EBC20170104.","journal-title":"Essays in Biochemistry"},{"issue":"4","key":"1116_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1242\/jcs.171017","volume":"130","author":"KH Flippo","year":"2017","unstructured":"Flippo, K. H., & Strack, S. (2017). Mitochondrial dynamics in neuronal injury, development and plasticity. Journal of Cell Science, 130(4), 671\u2013681. https:\/\/doi.org\/10.1242\/jcs.171017.","journal-title":"Journal of Cell Science"},{"issue":"3","key":"1116_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molmed.2017.01.003","volume":"23","author":"D Sebastian","year":"2017","unstructured":"Sebastian, D., Palacin, M., & Zorzano, A. (2017). Mitochondrial Dynamics: Coupling Mitochondrial Fitness with Healthy Aging. Trends in Molecular Medicine, 23(3), 201\u2013215. https:\/\/doi.org\/10.1016\/j.molmed.2017.01.003.","journal-title":"Trends in Molecular Medicine"},{"issue":"1","key":"1116_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.14348\/molcells.2018.2277","volume":"41","author":"SM Yoo","year":"2018","unstructured":"Yoo, S. M., & Jung, Y. K. (2018). A Molecular Approach to Mitophagy and Mitochondrial Dynamics. Molecules and Cells, 41(1), 18\u201326. https:\/\/doi.org\/10.14348\/molcells.2018.2277.","journal-title":"Molecules and Cells"},{"issue":"2","key":"1116_CR22","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11064-014-1377-0","volume":"40","author":"JC Corona","year":"2015","unstructured":"Corona, J. C., & Duchen, M. R. (2015). PPARgamma and PGC-1alpha as therapeutic targets in Parkinson\u2019s. Neurochemical Research, 40(2), 308\u2013316. https:\/\/doi.org\/10.1007\/s11064-014-1377-0.","journal-title":"Neurochemical Research"},{"key":"1116_CR23","doi-asserted-by":"publisher","unstructured":"Dominy J. E., Puigserver P. (2013). Mitochondrial biogenesis through activation of nuclear signaling proteins. Cold Spring Harbor Perspectives in Biology 5(7). https:\/\/doi.org\/10.1101\/cshperspect.a015008.","DOI":"10.1101\/cshperspect.a015008"},{"issue":"6","key":"1116_CR24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/s0092-8674(00)81410-5","volume":"92","author":"P Puigserver","year":"1998","unstructured":"Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998). A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell, 92(6), 829\u2013839. https:\/\/doi.org\/10.1016\/s0092-8674(00)81410-5.","journal-title":"Cell"},{"key":"1116_CR25","doi-asserted-by":"publisher","first-page":"113309","DOI":"10.1016\/j.expneurol.2020.113309","volume":"329","author":"EC Simmons","year":"2020","unstructured":"Simmons, E. C., Scholpa, N. E., & Schnellmann, R. G. (2020). Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases. Experimental Neurology, 329, 113309 https:\/\/doi.org\/10.1016\/j.expneurol.2020.113309.","journal-title":"Experimental Neurology"},{"issue":"38","key":"1116_CR26","doi-asserted-by":"publisher","first-page":"8233","DOI":"10.1523\/JNEUROSCI.0649-18.2018","volume":"38","author":"KH Flippo","year":"2018","unstructured":"Flippo, K. H., Gnanasekaran, A., Perkins, G. A., Ajmal, A., Merrill, R. A., Dickey, A. S., Taylor, S. S., McKnight, G. S., Chauhan, A. K., Usachev, Y. M., & Strack, S. (2018). AKAP1 Protects from Cerebral Ischemic Stroke by Inhibiting Drp1-Dependent Mitochondrial Fission. Journal of Neuroscience, 38(38), 8233\u20138242. https:\/\/doi.org\/10.1523\/JNEUROSCI.0649-18.2018.","journal-title":"Journal of Neuroscience"},{"key":"1116_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2016.06.023","volume":"100","author":"JC Corona","year":"2016","unstructured":"Corona, J. C., & Duchen, M. R. (2016). PPARgamma as a therapeutic target to rescue mitochondrial function in neurological disease. Free Radical Biology and Medicine, 100, 153\u2013163. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.06.023.","journal-title":"Free Radical Biology and Medicine"},{"issue":"1","key":"1116_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cns.12655","volume":"23","author":"M Golpich","year":"2017","unstructured":"Golpich, M., Amini, E., Mohamed, Z., Azman Ali, R., Mohamed Ibrahim, N., & Ahmadiani, A. (2017). Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment. CNS Neuroscience & Therapeutics, 23(1), 5\u201322. https:\/\/doi.org\/10.1111\/cns.12655.","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"1116_CR29","doi-asserted-by":"publisher","first-page":"107705","DOI":"10.1016\/j.pharmthera.2020.107705","volume":"219","author":"S Jamwal","year":"2021","unstructured":"Jamwal, S., Blackburn, J. K., & Elsworth, J. D. (2021). PPARgamma\/PGC1alpha signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders. Pharmacology & Therapeutics, 219, 107705 https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107705.","journal-title":"Pharmacology & Therapeutics"},{"key":"1116_CR30","doi-asserted-by":"publisher","unstructured":"Alvarez-Arellano L., Gonzalez-Garcia N., Salazar-Garcia M., Corona J. C. (2020). Antioxidants as a Potential Target against Inflammation and Oxidative Stress in Attention-Deficit\/Hyperactivity Disorder. Antioxidants 9(2). https:\/\/doi.org\/10.3390\/antiox9020176.","DOI":"10.3390\/antiox9020176"},{"issue":"11","key":"1116_CR31","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/1087054713510354","volume":"19","author":"N Joseph","year":"2015","unstructured":"Joseph, N., Zhang-James, Y., Perl, A., & Faraone, S. V. (2015). Oxidative Stress and ADHD: A Meta-Analysis. Journal of Attention Disorders, 19(11), 915\u2013924. https:\/\/doi.org\/10.1177\/1087054713510354.","journal-title":"Journal of Attention Disorders"},{"key":"1116_CR32","doi-asserted-by":"publisher","unstructured":"Corona J. C. (2020) Role of Oxidative Stress and Neuroinflammation in Attention-Deficit\/Hyperactivity Disorder. Antioxidants 9 (11). https:\/\/doi.org\/10.3390\/antiox9111039.","DOI":"10.3390\/antiox9111039"},{"issue":"4","key":"1116_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12402-015-0170-5","volume":"7","author":"AL Lopresti","year":"2015","unstructured":"Lopresti, A. L. (2015). Oxidative and nitrosative stress in ADHD: possible causes and the potential of antioxidant-targeted therapies. Attention Deficit and Hyperactivity Disorders, 7(4), 237\u2013247. https:\/\/doi.org\/10.1007\/s12402-015-0170-5.","journal-title":"Attention Deficit and Hyperactivity Disorders"},{"key":"1116_CR34","doi-asserted-by":"publisher","first-page":"956792","DOI":"10.1155\/2013\/956792","volume":"2013","author":"B Poljsak","year":"2013","unstructured":"Poljsak, B., Suput, D., & Milisav, I. (2013). Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants. Oxidative Medicine and Cellular Longevity, 2013, 956792 https:\/\/doi.org\/10.1155\/2013\/956792.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"2","key":"1116_CR35","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1159\/000485089","volume":"44","author":"L He","year":"2017","unstructured":"He, L., He, T., Farrar, S., Ji, L., Liu, T., & Ma, X. (2017). Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species. Cellular Physiology and Biochemistry, 44(2), 532\u2013553. https:\/\/doi.org\/10.1159\/000485089.","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"1","key":"1116_CR36","first-page":"10","volume":"6","author":"EK El Adham","year":"2011","unstructured":"El Adham, E. K., Hassan, A. I., & El Aziz El-Mahdy, A. A. (2011). Nutritional and Metabolic Disturbances in Attention Deficit Hyperactivity Disease. Research Journal of Medical Sciences, 6(1), 10\u201316.","journal-title":"Research Journal of Medical Sciences"},{"issue":"8","key":"1116_CR37","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.pnpbp.2010.08.010","volume":"34","author":"M Ceylan","year":"2010","unstructured":"Ceylan, M., Sener, S., Bayraktar, A. C., & Kavutcu, M. (2010). Oxidative imbalance in child and adolescent patients with attention-deficit\/hyperactivity disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(8), 1491\u20131494. https:\/\/doi.org\/10.1016\/j.pnpbp.2010.08.010.","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"1116_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/ijpvm.IJPVM_80_18","volume":"10","author":"S Nasim","year":"2019","unstructured":"Nasim, S., Naeini, A. A., Najafi, M., Ghazvini, M., & Hassanzadeh, A. (2019). Relationship between Antioxidant Status and Attention Deficit Hyperactivity Disorder Among Children. International Journal of Preventive Medicine, 10, 41 https:\/\/doi.org\/10.4103\/ijpvm.IJPVM_80_18.","journal-title":"International Journal of Preventive Medicine"},{"issue":"2","key":"1116_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1017\/neu.2013.35","volume":"26","author":"CM Comim","year":"2014","unstructured":"Comim, C. M., Gomes, K. M., Reus, G. Z., Petronilho, F., Ferreira, G. K., Streck, E. L., Dal-Pizzol, F., & Quevedo, J. (2014). Methylphenidate treatment causes oxidative stress and alters energetic metabolism in an animal model of attention-deficit hyperactivity disorder. Acta Neuropsychiatrica, 26(2), 96\u2013103. https:\/\/doi.org\/10.1017\/neu.2013.35.","journal-title":"Acta Neuropsychiatrica"},{"issue":"4","key":"1116_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s11011-012-9335-5","volume":"27","author":"F Schmitz","year":"2012","unstructured":"Schmitz, F., Scherer, E. B., Machado, F. R., da Cunha, A. A., Tagliari, B., Netto, C. A., & Wyse, A. T. (2012). Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats. Metabolic Brain Disease, 27(4), 605\u2013612. https:\/\/doi.org\/10.1007\/s11011-012-9335-5.","journal-title":"Metabolic Brain Disease"},{"issue":"1","key":"1116_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00702-016-1623-5","volume":"124","author":"M Motaghinejad","year":"2017","unstructured":"Motaghinejad, M., Motevalian, M., Shabab, B., & Fatima, S. (2017). Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats. Journal of Neural Transmission, 124(1), 121\u2013131. https:\/\/doi.org\/10.1007\/s00702-016-1623-5.","journal-title":"Journal of Neural Transmission"},{"issue":"6","key":"1116_CR42","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s11064-007-9544-1","volume":"33","author":"KM Gomes","year":"2008","unstructured":"Gomes, K. M., Petronilho, F. C., Mantovani, M., Garbelotto, T., Boeck, C. R., Dal-Pizzol, F., & Quevedo, J. (2008). Antioxidant enzyme activities following acute or chronic methylphenidate treatment in young rats. Neurochemical Research, 33(6), 1024\u20131027. https:\/\/doi.org\/10.1007\/s11064-007-9544-1.","journal-title":"Neurochemical Research"},{"key":"1116_CR43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.brainres.2017.01.028","volume":"1660","author":"OI Barygin","year":"2017","unstructured":"Barygin, O. I., Nagaeva, E. I., Tikhonov, D. B., Belinskaya, D. A., Vanchakova, N. P., & Shestakova, N. N. (2017). Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics. Brain Research 1660, 58\u201366. https:\/\/doi.org\/10.1016\/j.brainres.2017.01.028.","journal-title":"Brain Research"},{"issue":"2","key":"1116_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1476-5381.2010.00707.x","volume":"160","author":"AG Ludolph","year":"2010","unstructured":"Ludolph, A. G., Udvardi, P. T., Schaz, U., Henes, C., Adolph, O., Weigt, H. U., Fegert, J. M., Boeckers, T. M., & Fohr, K. J. (2010). Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations. British Journal of Pharmacology, 160(2), 283\u2013291. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00707.x.","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"1116_CR45","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1124\/jpet.114.217380","volume":"351","author":"SR Jesinkey","year":"2014","unstructured":"Jesinkey, S. R., Korrapati, M. C., Rasbach, K. A., Beeson, C. C., & Schnellmann, R. G. (2014). Atomoxetine prevents dexamethasone-induced skeletal muscle atrophy in mice. Journal of Pharmacology and Experimental Therapeutics, 351(3), 663\u2013673. https:\/\/doi.org\/10.1124\/jpet.114.217380.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"1116_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/neu.2007.0389","volume":"25","author":"WM Reid","year":"2008","unstructured":"Reid, W. M., & Hamm, R. J. (2008). Post-injury atomoxetine treatment improves cognition following experimental traumatic brain injury. Journal of Neurotrauma, 25(3), 248\u2013256. https:\/\/doi.org\/10.1089\/neu.2007.0389.","journal-title":"Journal of Neurotrauma"},{"issue":"3","key":"1116_CR47","first-page":"272","volume":"19","author":"QX Hou","year":"2016","unstructured":"Hou, Q. X., Yu, L., Tian, S. Q., Jiang, C. J., Yang, W. J., & Wang, Z. J. (2016). Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats. Iranian Journal of Basic Medical Sciences, 19(3), 272\u2013280.","journal-title":"Iranian Journal of Basic Medical Sciences"},{"key":"1116_CR48","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/978-81-322-2803-5_48","volume-title":"Melatonin, Neuroprotective Agents and Antidepressant Therapy","author":"BZ Altunkaynak","year":"2016","unstructured":"Altunkaynak, B. Z., Onger, M. E., Turkmen, A. P., Yurt, K. K., Altun, G., & Yuce, M. (2016). Effects of Methylphenidate and Atomoxetine on Development of the Brain. In F. L\u00f3pez-Mu\u00f1oz, V. Srinivasan, D. de Berardis, C. \u00c1lamo & A. T. Kato (eds), Melatonin, Neuroprotective Agents and Antidepressant Therapy (pp. 825\u2013845). New Delhi: Springer. pp."},{"key":"1116_CR49","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.bbrc.2020.10.072","volume":"534","author":"F Gur","year":"2021","unstructured":"Gur, F., Cengiz, M., & Gur, B. (2021). Alternations in nuclear factor kappa beta activity (NF-kB) in the rat brain due to long-term use of atomoxetine for treating ADHD: In vivo and in silico studies. Biochemical and Biophysical Research Communications, 534, 927\u2013932. https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.072.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"5","key":"1116_CR50","doi-asserted-by":"publisher","first-page":"e5546","DOI":"10.1371\/journal.pone.0005546","volume":"4","author":"C Tian","year":"2009","unstructured":"Tian, C., Murrin, L. C., & Zheng, J. C. (2009). Mitochondrial fragmentation is involved in methamphetamine-induced cell death in rat hippocampal neural progenitor cells. PLoS ONE, 4(5), e5546 https:\/\/doi.org\/10.1371\/journal.pone.0005546.","journal-title":"PLoS ONE"},{"key":"1116_CR51","doi-asserted-by":"publisher","unstructured":"Brillo V., Chieregato L., Leanza L., Muccioli S., Costa R. (2021). Mitochondrial Dynamics, ROS, and Cell Signaling: A Blended Overview. Life 11 (4). https:\/\/doi.org\/10.3390\/life11040332.","DOI":"10.3390\/life11040332"},{"issue":"2","key":"1116_CR52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cmet.2015.06.006","volume":"22","author":"PHGM Willems","year":"2015","unstructured":"Willems, P. H. G. M., Rossignol, R., Dieteren, C. E. J., Murphy, M. P., & Koopman, W. J. H. (2015). Redox Homeostasis and Mitochondrial Dynamics. Cell Metabolism, 22(2), 207\u2013218.","journal-title":"Cell Metabolism"},{"issue":"4","key":"1116_CR53","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.mito.2008.06.001","volume":"8","author":"M Jendrach","year":"2008","unstructured":"Jendrach, M., Mai, S., Pohl, S., Voth, M., & Bereiter-Hahn, J. (2008). Short- and long-term alterations of mitochondrial morphology, dynamics and mtDNA after transient oxidative stress. Mitochondrion, 8(4), 293\u2013304. https:\/\/doi.org\/10.1016\/j.mito.2008.06.001.","journal-title":"Mitochondrion"},{"key":"1116_CR54","doi-asserted-by":"publisher","first-page":"104435","DOI":"10.1016\/j.bioorg.2020.104435","volume":"105","author":"F Gur","year":"2020","unstructured":"Gur, F., Gur, B., Erkayman, B., Halici, Z., & Karakoc, A. (2020). Investigation of serum and brain superoxide dismutase levels depending on atomoxetine used in attention-deficit\/hyperactivity disorder treatment: A combination of in vivo and molecular docking studies. Bioorganic Chemistry, 105, 104435 https:\/\/doi.org\/10.1016\/j.bioorg.2020.104435.","journal-title":"Bioorganic Chemistry"},{"key":"1116_CR55","doi-asserted-by":"publisher","first-page":"112935","DOI":"10.1016\/j.physbeh.2020.112935","volume":"222","author":"M Dutt","year":"2020","unstructured":"Dutt, M., Dharavath, R. N., Kaur, T., Chopra, K., & Sharma, S. (2020). Differential effects of alprazolam against methylphenidate-induced neurobehavioral alterations. Physiology & Behavior, 222, 112935 https:\/\/doi.org\/10.1016\/j.physbeh.2020.112935.","journal-title":"Physiology & Behavior"},{"key":"1116_CR56","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2147\/DDDT.S50448","volume":"7","author":"PT Udvardi","year":"2013","unstructured":"Udvardi, P. T., Fohr, K. J., Henes, C., Liebau, S., Dreyhaupt, J., Boeckers, T. M., & Ludolph, A. G. (2013). Atomoxetine affects transcription\/translation of the NMDA receptor and the norepinephrine transporter in the rat brain\u2013an in vivo study. Drug Design, Development and Therapy, 7, 1433\u20131446. https:\/\/doi.org\/10.2147\/DDDT.S50448.","journal-title":"Drug Design, Development and Therapy"},{"key":"1116_CR57","doi-asserted-by":"publisher","unstructured":"Ramoz, N., Boni, C., Downing, A. M., Close, S. L., Peters, S. L., Prokop, A. M., Allen, A. J., Hamon, M., Purper-Ouakil, D., & Gorwood, P. (2009). A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD. Neuropsychopharmacology, 34(9), 2135\u20132142. https:\/\/doi.org\/10.1038\/npp.2009.39.","DOI":"10.1038\/npp.2009.39"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-022-01116-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-022-01116-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-022-01116-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T02:25:13Z","timestamp":1676341513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-022-01116-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1116"],"URL":"https:\/\/doi.org\/10.1007\/s12013-022-01116-x","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"29 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All authors agreed with the content and gave explicit consent to submit before submission of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}